Egg prices plunge as avian flu impact eases, but risks remain

Egg prices fell 3.8% in February and are down 42.1% year-over-year, with retail dozen prices that peaked at $6.22 in March 2025 now about $2.50. Production recovery and USDA mitigation efforts have normalized supply, but recent USDA wildlife monitoring detected very high viral loads in migratory birds across all four U.S. flyways and roughly 14 million birds affected in the past 30 days (including ~4 million detections in March), creating a tangible upside risk to prices if large flock-level outbreaks recur.

Analysis

The price reversal in eggs masks a structurally higher tail-risk because production is concentrated in large, highly automated layer farms where a single detection can remove a disproportionate share of national supply. That asymmetry amplifies volatility: when a ~1–4M bird house is depopulated, physical supply can tighten on a multi-week cadence driven by birds reaching laying age, not by immediate restocking, creating sharp one- to three-month price spikes even if average annual supply recovers.

Second-order winners from the decline in egg costs are grocery retailers and high-volume foodservice operators that use eggs as a pass-through ingredient; their near-term gross-margin improvement is predictable and will show up in next 1–3 quarters of reported results unless a large outbreak recurs. Conversely, specialist egg producers and integrators face binary downside from outbreak headlines and slower recovery of flock productivity, and the indemnity framework leaves them exposed to idiosyncratic cashflow shocks.

Key catalysts to watch over the coming months are: (A) USDA/state surveillance releases and any single-farm detections >1M birds (an immediate price shock trigger within 2–8 weeks), (B) seasonal migratory patterns that increase wild-bird viral load, and (C) incremental adoption of biosecurity/capital spend by large integrators which mutes long-run frequency of outbreaks. These create asymmetric payoffs for volatility instruments and for names exposed to consumer staples margins versus concentrated producers.

Key Decisions for Investors

• Volatility play on concentrated producers — buy a CALM 3-month ATM straddle (size 0.5–1.0% portfolio). Rationale: captures idiosyncratic large-farm detection spikes that can move the equity >30% quickly; risk = premium paid, reward = unlimited upside from a supply shock. Exit/trim on 40% move in CALM or 50% gain on option premium.
• Retail/consumer margin long — overweight Kroger (KR) via a 6-month call spread (size 1–2% portfolio). Rationale: sustained lower egg input should lift grocery gross margins for 2–4 quarters and compound EPS upside of ~3–7% vs consensus if deflation persists. Set stop-loss if share falls 6% and take profits on 8–12% relative outperformance vs XLP over 3–6 months.
• Animal health/diagnostics long — buy Zoetis (ZTS) or IDEXX (IDXX) 9–12 month call spreads (size 0.5–1%). Rationale: increased surveillance, testing and biosecurity capex supports durable revenue tail for diagnostics and vaccines; expect 3:1 upside/downside on targeted outbreaks or policy-driven surveillance increases.
• Feed-price hedge — establish a small short position in corn exposure (e.g., CORN ETF put spread) sized 0.25–0.5% to capture downside risk to feed demand from persistent flock reductions. Rationale: large-scale depopulations depress feed demand and can pressure corn/soy near-term; use limited-loss spread to hedge option and equity exposures.